Alzheimer’s disease is the most common cause of dementia and affects millions of people around the world. It is a progressive brain disease, which means it slowly becomes worse over time.
People with Alzheimer’s gradually lose their memory, thinking ability, language skills, and independence. Simple daily activities, such as preparing meals, recognizing family members, or finding the right words, can become difficult.
As the disease advances, patients often need full-time care. Despite many years of research, there is still no cure, making the search for better treatments one of the biggest challenges in medicine.
Scientists know that one of the main features of Alzheimer’s disease is the buildup of harmful proteins called amyloid beta inside the brain. These proteins stick together and form plaques that damage nerve cells. Another problem is ongoing inflammation in the brain, which can further injure brain tissue.
Current treatments can help relieve symptoms or slow the disease slightly, but they cannot stop Alzheimer’s completely. Some newer antibody-based medicines can remove some amyloid, but they are very expensive, offer only modest benefits, and may cause serious side effects related to the immune system.
Now, researchers from Kindai University in Japan have discovered that a common dietary supplement called arginine may offer a new and much simpler approach. Their findings were published in the journal Neurochemistry International.
Arginine is a natural amino acid that the body uses to make proteins. It is found in foods such as meat, fish, dairy products, nuts, seeds, and beans. It is also widely sold as a dietary supplement because it helps produce nitric oxide, a substance that relaxes blood vessels and improves blood flow.
Because arginine has already been used safely for other medical purposes, scientists believe it may be easier to study as a possible treatment for Alzheimer’s disease.
The research was led by graduate student Kanako Fujii, Professor Yoshitaka Nagai, and Associate Professor Toshihide Takeuchi. The team first carried out laboratory experiments to see whether arginine could affect amyloid beta proteins.
They found that arginine slowed the process in which amyloid beta 42 proteins clump together, reducing the formation of the harmful protein clusters linked to Alzheimer’s disease.
The scientists then tested arginine in two different animal models of Alzheimer’s disease. One model used fruit flies with a genetic mutation that causes Alzheimer’s-like symptoms, while the other used mice carrying several genetic changes associated with the disease in humans.
The results were encouraging. In both animal models, arginine greatly reduced the buildup of amyloid proteins and lowered their harmful effects. In the mice, the treatment also improved brain health.
The animals had fewer amyloid plaques, lower levels of amyloid beta 42, and less inflammation in the brain. They also showed better behavior compared with untreated mice.
According to Professor Nagai, arginine is attractive because it is already considered safe, inexpensive, and able to enter the brain. The researchers believe it may not only reduce harmful protein buildup but also protect brain cells and reduce inflammation, both of which are important in slowing Alzheimer’s disease.
This work is an example of drug repositioning, which means finding a new medical use for a substance that is already approved or widely available. Because arginine has already been approved for medical use in Japan, the path toward human clinical trials may be faster than developing an entirely new drug.
The researchers emphasize that these findings do not mean people should start taking arginine supplements to prevent or treat Alzheimer’s on their own.
The study was carried out in laboratory experiments and animal models, and researchers still need to discover the safest and most effective dose for people. Carefully designed clinical trials will be needed before doctors can recommend arginine as a treatment.
Even so, the study offers new hope. If future human studies confirm these findings, a simple, low-cost supplement could one day become part of the fight against one of the world’s most devastating brain diseases, making treatment more affordable and accessible for millions of people.
If you care about Alzheimer’s disease, please read studies that bad lifestyle habits can cause Alzheimer’s disease, and strawberries can be good defence against Alzheimer’s.
For more information about brain health, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
